Navigation Links
Scientists uncover protective mechanism against liver cancer
Date:12/14/2009

A team of scientists from the UC San Diego School of Medicine and Osaka University in Japan have identified a protein switch that helps prevent liver damage, including inflammation, fibrosis and cancer. The findings suggest that a better understanding of how the protein, TAK1, works could lead to new insights into the development of liver disease and cancer.

"TAK1 appears to be a master regulator of liver function," said David A. Brenner, MD, professor of medicine and Dean of the UC San Diego School of Medicine. He and Ekihiro Seki, MD, PhD, assistant research scientist in the Department of Medicine, led the work. "Understanding its role in liver disease and cancer may eventually enable us to devise new therapeutic strategies." Their study appears on line the week of December 14 in advance of publication in the journal Proceedings of the National Academy of Sciences.

TAK1 is a kinase, a type of signaling protein involved in regulating various cell activities, including cell growth. Researchers have known that TAK1 activates two specific proteins, NF-kappaB and JNK, which are both involved in immunity, inflammation, programmed cell death and cancer. But NF-kappaB helps protect liver cells from dying and protects against cancer development. In contrast, JNK promotes cell death and cancer.

However, it has been unclear whether TAK1 promotes or prevents the development of liver cancer. To find out, Seki, Brenner and their group created a mouse model in which liver cells lacked the gene Tak1, which makes the TAK1 protein. In a series of experiments, they found a high rate of liver cell death in young animals lacking TAK1. The animals' livers then went into overdrive, producing too many liver cells to make up for the loss and causing liver damage, including inflammation and fibrosis liver scarring and eventually, cancer.

According to Seki, the study is the first to demonstrate the role of TAK1 in cancer development, and strongly suggests that the protein also contributes to cancer development in other organs. In addition, the liver cancer mouse model that the team developed is associated with sustained liver inflammation and fibrosis key features of human liver cancer and should be useful in investigating whether fibrosis influences liver cancer development.

"We can also use the model to test whether a potential cancer drug or therapy affects both fibrosis and cancer, or either one," Seki said. "This study will open a new therapeutic potential targeting the expression of TAK1 for liver cancer."


'/>"/>

Contact: Steve Benowitz
sbenowitz@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. UNC scientists coordinate study of link between insulin use and cancer in people with diabetes
2. Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods
3. NeuroFocus Adds Two More of the Worlds Leading Neuroscientists to its Advisory Board
4. Scripps Research scientists reveal key structure from ebola virus
5. Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists
6. Caltech scientists show how ubiquitin chains are added to cell-cycle proteins
7. Vanderbilt scientists report first effective medical therapy for rare stomach disorder
8. Childrens Hospital Oakland scientists discover soy component may be key to fighting colon cancer
9. BIDMC scientists awarded grants from Michael J. Fox Foundation for Parkinsons research
10. Scientists find molecular trigger that helps prevent aging and disease
11. Chinese Scientists Develop Database on the Liver
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... 2017 , ... Axiad IDS , a leading provider of trusted identities ... the company a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this ... and proactively address potential cybersecurity threats before they happen. The annual list ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... and a 2017 Best in KLAS category winner, has named Daniel P. Bullington ... extend and enhance its technology platform and product offerings,” says Justin Neece, president. ...
(Date:5/23/2017)... ... May 23, 2017 , ... Drs. ... on peri-implantitis in Las Vegas, NV, and the importance of treating ... disease consultation and leading care for peri-implantitis, with or without a referral. As ...
(Date:5/23/2017)... Diego, CA (PRWEB) , ... May 23, 2017 , ... ... bleeding gums and chronic bad breath, can now receive laser gum disease treatments from ... R. Douglas Campbell and David Landau are raising awareness of the importance of receiving ...
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental and endodontic ... in Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists ... One or more sedation methods may be recommended based on the severity of the ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... -- MACRA replaces the outdated sustainable growth rate ... Black Book Research crowdsource-surveyed 8,845 physician practices from February ... for MIPS Compliance Technology is Booming ... or more clinicians seek to buy Merit-Based Incentive Payment ... of the changes, the hunt is on for the ...
(Date:5/4/2017)... 2017  Fortuna Fix Inc. (" Fortuna "), a ... to eliminate the need for embryonic and fetal stem cells ... diseases. Fortuna announced today the launch ... Fehlings , MD, PhD; Father Kevin FitzGerald , S.J., ... Professor James Giordano , PhD. "We are ...
(Date:5/4/2017)...  A new tight-tolerance microextrusion medical tubing product ... is being launched by Natvar, a Tekni-Plex company. ... recent years to service a wide variety of ... expensive materials such as glass and fluoropolymers have ... their ability to consistently hold tolerances. This is ...
Breaking Medicine Technology: